All Insights and Resources

Allogeneic

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

1 December 2021

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

News

Takeda Set to Acquire GammaDelta Therapeutics, Accelerating Allogeneic Cell Therapy Development for Solid Tumours

28 October 2021

Takeda Set to Acquire GammaDelta Therapeutics, Accelerating Allogeneic Cell Therapy Development for Solid Tumours

News

Achieving Automation in Cell Therapy, Selection, Sampling and Washing

19 October 2021

Achieving Automation in Cell Therapy, Selection, Sampling and Washing

Event Report

Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products

7 October 2019

Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products

Allogeneic cell therapies are poised

POPULAR NEWS ITEMS

1 December 2021

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

26 November 2021

Top in Tech: Technology Demonstration Library

23 November 2021

Advanced Therapies Investment Round-Up: Biotech on Cloud 9

RECOMENDED TOPICS

Tissue Engineering

Viral/Non-Viral Vectors

POPULAR NEWS ITEMS

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

Top in Tech: Technology Demonstration Library

Advanced Therapies Investment Round-Up: Biotech on Cloud 9

logo_mobile_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2021

We use Cookies to improve your experience on our site. Learn More